VBIV logo

VBI Vaccines (VBIV) Cash From Investing

Annual CFI

-$867.00 K
+$3.48 M+80.04%

December 31, 2023

Summary

Performance

1-Year Change

+80.04%

3-Year Change

+96.67%

5-Year Change

+85.53%

15-Year Change

-49.74%

VBIV Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$23.16 M
VBIV annual cash flow from investing activities is currently -103.74% below its historical high of $23.16 million

3-Year Low

-$4.34 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VBIV previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
VBIV next annual earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

Annual CFF

$22.70 M
VBIV annual cash flow from financing activities is $22.70 million

Annual CFO

-$60.88 M
VBIV annual cash flow from operations is -$60.88 million

Annual FCF

-$61.75 M
VBIV annual free cash flow is -$61.75 million

Annual CAPEX

$867.00 K
VBIV annual capital expenditures is $867.00 thousand

Quarterly CFI

-$151.00 K
+$19.00 K+11.18%

March 31, 2024

Summary

Performance

3-Month Change

+11.18%

1-Year Change

-202%

3-Year Change

+89.6%

5-Year Change

+89.6%

VBIV Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$24.75 M
VBIV quarterly cash flow from investing activities is currently -100.61% below its historical high of $24.75 million

3-Year Low

-$1.45 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
VBIV previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
VBIV next earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

Quarterly CFF

$843.00 K
VBIV quarterly cash flow from financing activities is $843.00 thousand

Quarterly CFO

-$11.77 M
VBIV quarterly cash flow from operations is -$11.77 million

Quarterly FCF

-$11.92 M
VBIV quarterly free cash flow is -$11.92 million

Quarterly CAPEX

$151.00 K
VBIV quarterly capital expenditures is $151.00 thousand

TTM CFI

-$484.00 K
+$383.00 K+44.18%

March 31, 2024

Summary

Performance

3-Month Change

+44.18%

1-Year Change

+85.49%

3-Year Change

+88.86%

5-Year Change

+88.86%

VBIV TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$23.46 M
VBIV TTM cash flow from investing activities is currently -102.06% below its historical high of $23.46 million

3-Year Low

-$4.36 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
VBIV previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
VBIV next earnings announcement has not yet been scheduled

OtherVBIVcash flowmetrics:

TTM CFF

$23.54 M
VBIV TTM cash flow from financing activities is $23.54 million

TTM CFO

-$51.00 M
VBIV TTM cash flow from operations is -$51.00 million

TTM FCF

-$51.48 M
VBIV TTM free cash flow is -$51.48 million

TTM CAPEX

$484.00 K
VBIV TTM capital expenditures is $484.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

VBIV Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+80.0%-202.0%+85.5%
3 y3 years+96.7%+89.6%+88.9%
5 y5 years+85.5%+89.6%+88.9%

VBIV Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.7%+401.0%+202.0%+861.6%-102.1%+801.4%
5 y5-year-103.7%+2898.8%-100.6%>+9999.0%-102.1%+5359.3%
alltimeall time-103.7%+2898.8%-100.6%>+9999.0%-102.1%+5359.3%

VBI Vaccines Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2024
-
-$151.00 K(-11.2%)
-$484.00 K(-44.2%)
Dec 2023
-$867.00 K(-80.0%)
-$170.00 K(+50.4%)
-$867.00 K(-59.7%)
Sep 2023
-
-$113.00 K(+126.0%)
-$2.15 M(-35.6%)
Jun 2023
-
-$50.00 K(-90.6%)
-$3.34 M(-23.5%)
Mar 2023
-
-$534.00 K(-63.2%)
-$4.36 M(+0.4%)
Dec 2022
-$4.34 M(-118.8%)
-$1.45 M(+11.7%)
-$4.34 M(+24.0%)
Sep 2022
-
-$1.30 M(+20.7%)
-$3.50 M(+33.3%)
Jun 2022
-
-$1.08 M(+109.1%)
-$2.63 M(-111.3%)
Mar 2022
-
-$515.00 K(-15.6%)
$23.20 M(+0.2%)
Dec 2021
$23.16 M(-189.1%)
-$610.00 K(+43.5%)
$23.16 M(-0.3%)
Sep 2021
-
-$425.00 K(-101.7%)
$23.23 M(-1.0%)
Jun 2021
-
$24.75 M(-4550.9%)
$23.46 M(-188.8%)
Mar 2021
-
-$556.00 K(+4.5%)
-$26.42 M(+1.6%)
Dec 2020
-$26.00 M(+607.9%)
-$532.00 K(+166.0%)
-$26.00 M(+1.3%)
Sep 2020
-
-$200.00 K(-99.2%)
-$25.65 M(-1.5%)
Jun 2020
-
-$25.14 M(>+9900.0%)
-$26.04 M(+1263.4%)
Mar 2020
-
-$133.00 K(-28.5%)
-$1.91 M(-48.0%)
Dec 2019
-$3.67 M(-38.7%)
-$186.00 K(-68.3%)
-$3.67 M(-37.3%)
Sep 2019
-
-$586.00 K(-41.7%)
-$5.86 M(-14.5%)
Jun 2019
-
-$1.00 M(-47.0%)
-$6.86 M(-0.2%)
Mar 2019
-
-$1.90 M(-20.1%)
-$6.87 M(+14.7%)
Dec 2018
-$5.99 M(+935.1%)
-$2.37 M(+50.1%)
-$5.99 M(+63.2%)
Sep 2018
-
-$1.58 M(+54.8%)
-$3.67 M(+67.4%)
Jun 2018
-
-$1.02 M(+0.7%)
-$2.19 M(+65.2%)
Mar 2018
-
-$1.01 M(+1815.1%)
-$1.33 M(+129.4%)
Dec 2017
-$579.00 K(-138.6%)
-$53.00 K(-49.0%)
-$579.00 K(-7.5%)
Sep 2017
-
-$104.00 K(-33.3%)
-$626.00 K(-20.7%)
Jun 2017
-
-$156.00 K(-41.4%)
-$789.00 K(-157.7%)
Mar 2017
-
-$266.00 K(+166.0%)
$1.37 M(-8.9%)
Dec 2016
$1.50 M(-92.6%)
-$100.00 K(-62.5%)
$1.50 M(-6.3%)
Sep 2016
-
-$267.00 K(-113.3%)
$1.60 M(-14.3%)
Jun 2016
-
$2.00 M(-1603.8%)
$1.87 M(-1503.8%)
Mar 2016
-
-$133.00 K(<-9900.0%)
-$133.00 K(-98.5%)
Dec 2015
$20.31 M(-312.8%)
-
-
Jun 2015
-
$0.00(-100.0%)
-$8.75 M(-8.3%)
Mar 2015
-
$876.20 K(-109.2%)
-$9.54 M(-7.8%)
Mar 2015
-$9.54 M(+387.8%)
-
-
Dec 2014
-
-$9.52 M(+9501.6%)
-$10.36 M(+1242.3%)
Sep 2014
-
-$99.20 K(-87.5%)
-$771.50 K(+12.0%)
Jun 2014
-
-$796.70 K(-1331.4%)
-$689.00 K(-64.8%)
Mar 2014
-$1.96 M(-6.0%)
$64.70 K(+8.4%)
-$1.96 M(-52.2%)
Dec 2013
-
$59.70 K(-457.5%)
-$4.09 M(-1.4%)
Sep 2013
-
-$16.70 K(-99.2%)
-$4.15 M(+0.4%)
Jun 2013
-
-$2.06 M(-0.2%)
-$4.13 M(+98.6%)
Mar 2013
-$2.08 M(-3034.7%)
-$2.07 M(<-9900.0%)
-$2.08 M(>+9900.0%)
Dec 2012
-
$400.00(-200.0%)
-$15.70 K(-110.9%)
Sep 2012
-
-$400.00(-96.6%)
$143.40 K(+143.1%)
Jun 2012
-
-$11.90 K(+213.2%)
$59.00 K(-16.8%)
Mar 2012
$70.90 K
-$3800.00(-102.4%)
$70.90 K(-99.3%)
Dec 2011
-
$159.50 K(-288.1%)
$9.51 M(-9.0%)
Sep 2011
-
-$84.80 K(<-9900.0%)
$10.45 M(-16.2%)
DateAnnualQuarterlyTTM
Jun 2011
-
$0.00(-100.0%)
$12.47 M(+0.2%)
Mar 2011
$12.45 M(-832.9%)
$9.44 M(+762.2%)
$12.45 M(+469.0%)
Dec 2010
-
$1.09 M(-43.5%)
$2.19 M(+168.8%)
Sep 2010
-
$1.94 M(-9113.5%)
$813.70 K(-152.1%)
Jun 2010
-
-$21.50 K(-97.4%)
-$1.56 M(-8.1%)
Mar 2010
-$1.70 M(+2044.3%)
-$823.50 K(+194.9%)
-$1.70 M(+76.0%)
Dec 2009
-
-$279.20 K(-36.0%)
-$964.70 K(+43.8%)
Sep 2009
-
-$436.40 K(+174.3%)
-$671.00 K(+185.9%)
Jun 2009
-
-$159.10 K(+76.8%)
-$234.70 K(+196.3%)
Mar 2009
-$79.20 K(-72.0%)
-$90.00 K(-720.7%)
-$79.20 K(-298.0%)
Dec 2008
-
$14.50 K(<-9900.0%)
$40.00 K(-124.9%)
Sep 2008
-
-$100.00(-97.2%)
-$160.50 K(-23.8%)
Jun 2008
-
-$3600.00(-112.3%)
-$210.50 K(-25.7%)
Mar 2008
-$283.10 K(-28.0%)
$29.20 K(-115.7%)
-$283.20 K(-9.4%)
Dec 2007
-
-$186.00 K(+271.3%)
-$312.70 K(-38.9%)
Sep 2007
-
-$50.10 K(-34.3%)
-$511.50 K(+13.2%)
Jun 2007
-
-$76.30 K(>+9900.0%)
-$451.70 K(+14.9%)
Mar 2007
-$393.10 K(+82.8%)
-$300.00(-99.9%)
-$393.20 K(-14.2%)
Dec 2006
-
-$384.80 K(-4067.0%)
-$458.20 K(+383.8%)
Sep 2006
-
$9700.00(-154.5%)
-$94.70 K(-40.8%)
Jun 2006
-
-$17.80 K(-72.7%)
-$160.10 K(-25.5%)
Mar 2006
-$215.00 K(-8.0%)
-$65.30 K(+206.6%)
-$215.00 K(+10.7%)
Dec 2005
-
-$21.30 K(-61.8%)
-$194.20 K(-15.7%)
Sep 2005
-
-$55.70 K(-23.4%)
-$230.40 K(-24.1%)
Jun 2005
-
-$72.70 K(+63.4%)
-$303.70 K(+30.0%)
Mar 2005
-$233.70 K(+463.1%)
-$44.50 K(-22.6%)
-$233.70 K(+23.5%)
Dec 2004
-
-$57.50 K(-55.4%)
-$189.30 K(+89.5%)
Sep 2004
-
-$129.00 K(+4677.8%)
-$99.90 K(+126.5%)
Jun 2004
-
-$2700.00(+2600.0%)
-$44.10 K(+6.0%)
Mar 2004
-$41.50 K(+446.1%)
-$100.00(-100.3%)
-$41.60 K(-53.2%)
Dec 2003
-
$31.90 K(-143.6%)
-$88.90 K(-13.8%)
Sep 2003
-
-$73.20 K(>+9900.0%)
-$103.10 K(+418.1%)
Jun 2003
-
-$200.00(-99.6%)
-$19.90 K(+165.3%)
Mar 2003
-$7600.00(-71.1%)
-$47.40 K(-367.8%)
-$7500.00(-124.7%)
Dec 2002
-
$17.70 K(+77.0%)
$30.40 K(+234.1%)
Sep 2002
-
$10.00 K(-18.0%)
$9100.00(-163.2%)
Jun 2002
-
$12.20 K(-228.4%)
-$14.40 K(-45.2%)
Mar 2002
-$26.30 K(+4.8%)
-$9500.00(+163.9%)
-$26.30 K(+46.1%)
Dec 2001
-
-$3600.00(-73.3%)
-$18.00 K(-17.8%)
Sep 2001
-
-$13.50 K(-4600.0%)
-$21.90 K(-11.7%)
Jun 2001
-
$300.00(-125.0%)
-$24.80 K(-1.2%)
Mar 2001
-$25.10 K(<-9900.0%)
-$1200.00(-84.0%)
-$25.10 K(+5.0%)
Dec 2000
-
-$7500.00(-54.3%)
-$23.90 K(+45.7%)
Sep 2000
-
-$16.40 K(<-9900.0%)
-$16.40 K(<-9900.0%)
Jun 2000
-
$0.00(-100.0%)
$0.00(-100.0%)
Mar 2000
$0.00(-100.0%)
-
-
Mar 1999
-$66.30 K(-5.8%)
-
-
Mar 1998
-$70.40 K(<-9900.0%)
-$600.00(-124.0%)
-$70.50 K(+0.9%)
Dec 1997
-
$2500.00(-103.5%)
-$69.90 K(-3.5%)
Sep 1997
-
-$72.40 K(<-9900.0%)
-$72.40 K(<-9900.0%)
Jun 1997
-
$0.00
$0.00
Mar 1997
$0.00
-
-

FAQ

  • What is VBI Vaccines annual cash flow from investing activities?
  • What is the all time high annual CFI for VBI Vaccines?
  • What is VBI Vaccines annual CFI year-on-year change?
  • What is VBI Vaccines quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for VBI Vaccines?
  • What is VBI Vaccines quarterly CFI year-on-year change?
  • What is VBI Vaccines TTM cash flow from investing activities?
  • What is the all time high TTM CFI for VBI Vaccines?
  • What is VBI Vaccines TTM CFI year-on-year change?

What is VBI Vaccines annual cash flow from investing activities?

The current annual CFI of VBIV is -$867.00 K

What is the all time high annual CFI for VBI Vaccines?

VBI Vaccines all-time high annual cash flow from investing activities is $23.16 M

What is VBI Vaccines annual CFI year-on-year change?

Over the past year, VBIV annual cash flow from investing activities has changed by +$3.48 M (+80.04%)

What is VBI Vaccines quarterly cash flow from investing activities?

The current quarterly CFI of VBIV is -$151.00 K

What is the all time high quarterly CFI for VBI Vaccines?

VBI Vaccines all-time high quarterly cash flow from investing activities is $24.75 M

What is VBI Vaccines quarterly CFI year-on-year change?

Over the past year, VBIV quarterly cash flow from investing activities has changed by -$101.00 K (-202.00%)

What is VBI Vaccines TTM cash flow from investing activities?

The current TTM CFI of VBIV is -$484.00 K

What is the all time high TTM CFI for VBI Vaccines?

VBI Vaccines all-time high TTM cash flow from investing activities is $23.46 M

What is VBI Vaccines TTM CFI year-on-year change?

Over the past year, VBIV TTM cash flow from investing activities has changed by +$2.85 M (+85.49%)